Neurocrine Biosciences
NBIX
#1296
Rank
โ‚ฌ15.90 B
Marketcap
157,16ย โ‚ฌ
Share price
3.12%
Change (1 day)
23.64%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): 1,83ย โ‚ฌ

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is 6,28ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 1,45ย โ‚ฌ an increase over its 2021 EPS that were of 0,86ย โ‚ฌ.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)1,83ย โ‚ฌ26.22%
20221,45ย โ‚ฌ69.47%
20210,86ย โ‚ฌ-78.21%
20203,93ย โ‚ฌ990%
20190,36ย โ‚ฌ81.82%
20180,20ย โ‚ฌ-113.5%
2017-1,47ย โ‚ฌ0.62%
2016-1,46ย โ‚ฌ57.28%
2015-0,93ย โ‚ฌ25.61%
2014-0,74ย โ‚ฌ18.84%
2013-0,62ย โ‚ฌ-1085.71%
20120,06308ย โ‚ฌ-89.71%
20110,61ย โ‚ฌ-500%
2010-0,15ย โ‚ฌ-86.92%
2009-1,17ย โ‚ฌ-43.48%
2008-2,07ย โ‚ฌ-57.8%
2007-4,91ย โ‚ฌ92.58%
2006-2,55ย โ‚ฌ371.67%
2005-0,54ย โ‚ฌ-52.76%
2004-1,14ย โ‚ฌ36.56%
2003-0,84ย โ‚ฌ-70%
2002-2,79ย โ‚ฌ118.31%
2001-1,28ย โ‚ฌ8.4%
2000-1,18ย โ‚ฌ59.18%
1999-0,74ย โ‚ฌ-20%
1998-0,93ย โ‚ฌ-479.31%
19970,24ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
0,64ย โ‚ฌ-89.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
5,27ย โ‚ฌ-16.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
27,84ย โ‚ฌ 343.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-0,18ย โ‚ฌ-102.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-1,83ย โ‚ฌ-129.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
4,67ย โ‚ฌ-25.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-6,80ย โ‚ฌ-208.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
1,38ย โ‚ฌ-78.06%๐Ÿ‡ฌ๐Ÿ‡ง UK